MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 215 filers reported holding MYRIAD GENETICS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $55,711,427 | -26.1% | 3,473,281 | +6.7% | 0.32% | -23.9% |
Q2 2023 | $75,422,574 | +6.1% | 3,253,778 | +6.3% | 0.42% | +2.7% |
Q1 2023 | $71,103,267 | +48.3% | 3,060,838 | -7.4% | 0.41% | +39.8% |
Q4 2022 | $47,947,657 | -61.8% | 3,304,456 | -49.7% | 0.29% | -65.1% |
Q3 2022 | $125,363,000 | +6.8% | 6,570,402 | +1.7% | 0.84% | +7.7% |
Q2 2022 | $117,417,000 | -25.8% | 6,462,138 | +2.9% | 0.78% | -16.5% |
Q1 2022 | $158,182,000 | -9.3% | 6,277,060 | -0.6% | 0.94% | -6.9% |
Q4 2021 | $174,332,000 | -13.6% | 6,316,365 | +1.0% | 1.01% | -18.5% |
Q3 2021 | $201,871,000 | +6.6% | 6,251,811 | +0.9% | 1.23% | +10.9% |
Q2 2021 | $189,397,000 | -13.4% | 6,193,479 | -13.8% | 1.11% | -14.8% |
Q1 2021 | $218,794,000 | +64.4% | 7,185,350 | +6.7% | 1.31% | +42.1% |
Q4 2020 | $133,114,000 | +106.4% | 6,731,429 | +36.1% | 0.92% | +65.5% |
Q3 2020 | $64,491,000 | +19.4% | 4,945,610 | +3.9% | 0.56% | +9.0% |
Q2 2020 | $53,991,000 | -9.3% | 4,761,082 | +14.4% | 0.51% | -24.0% |
Q1 2020 | $59,534,000 | -39.2% | 4,160,284 | +15.6% | 0.67% | -12.9% |
Q4 2019 | $97,994,000 | +1.0% | 3,598,750 | +6.2% | 0.77% | -12.1% |
Q3 2019 | $97,006,000 | – | 3,388,249 | – | 0.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |